Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged

Author:

Williams William V.123ORCID,Brind Joel4,Haynes Laura5,Manhart Michael D.6ORCID,Klaus Hanna37,Lanfranchi Angela348,Migeon Gerard9,Gaskins Mike10,Seman Elvis I.111213,Ruppersberger Lester3,Raviele Kathleen M.3

Affiliation:

1. BriaCell Therapeutics Corporation, Berkeley, CA, USA

2. University of Pennsylvania, Philadelphia, PA, USA

3. Catholic Medical Association, Fort Washington, PA, USA

4. Breast Cancer Prevention Institute, Whitehouse Station, NJ, USA

5. International Federation for Therapeutic and Counseling Choice, General Board Member and USA Country Representative, Tustin, California, USA

6. Couple to Couple League, Cincinnati, OH, USA

7. Teen STAR, Tallahassee, FL, USA

8. Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA

9. Natural Womanhood, San Antonio, TX, USA

10. Independent Author, Ft. Worth, TX, USA

11. Associate Professor of Obstetrics, Gynaecology and Reproductive Medicine, Flinders University, Adelaide, South Australia

12. Medical Lead in Urogynaecology, Flinders Medical Centre, Australia

13. Senior VMS in Gynaecology, The Queen Elizabeth and Royal Adelaide Hospitals, South Australia

Abstract

Hormonal contraceptives have been on the market for over fifty years and, while their formulations have changed, the basic mechanism of action has remained the same. During this time, numerous studies have been performed documenting side effects, some of which appear over time, some within weeks or months, but all can have a serious impact on health and quality of life. An effort was made to perform a series of comprehensive literature surveys to better understand immediate and long-term side effects of these agents. The results of this literature review uncovered a number of potential side effects, some of which are acknowledged and many of which are not noted in the prescribing information for these agents. Among the unacknowledged side effects are: an increased risk of HIV transmission for depot medroxyprogesterone acetate (DMPA), and for combination contraceptives breast cancer, cervical cancer, Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, depression, mood disorders and suicides (especially among women twenty-five years of age and younger, in the first six months of use), multiple sclerosis, interstitial cystitis, female sexual dysfunction, osteoporotic bone fractures (especially for progesterone-only contraceptives), and fatty weight gain. Misleading prescribing information regarding cardiovascular and thrombotic risks are also noted. Women seeking birth control have a right to be informed and educated about risk avoidance through the use of effective nonhormonal methods like fertility awareness methods. In one case—that of DMPA—the increased risk of HIV acquisition has been conclusively demonstrated to be both real and unique to this drug. Considering the availability of numerous alternatives, there is no justification for the continued marketing of DMPA to the public. Summary: We reviewed the effect of hormonal contraceptives on women’s health. A number of potential side effects were noted including increased risks of breast cancer, cervical cancer, inflammatory bowel  disease, lupus, multiple sclerosis, cystitis, bone fractures, depression, mood disorders and suicides,  fatty weight gain, and female sexual dysfunction.  With the long-acting injectable contraceptives there is an increased risk of getting HIV.  Misleading prescribing information regarding the risks of heart attacks, strokes and blood clotting problems were also noted. Women seeking birth control have a right to know about how to avoid these risks by using effective hormone-free Fertility Awareness Methods.

Publisher

SAGE Publications

Subject

Health Policy,Philosophy

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3